snabelen.no er en av mange uavhengige Mastodon-servere du kan bruke for å delta i det desentraliserte sosiale nettet.
Ein norsk heimstad for den desentraliserte mikroblogge-plattformen.

Administrert av:

Serverstatistikk:

380
aktive brukere

#pharma

ett innlegg1 deltaker0 innlegg i dag

Open Source Software Adoption in Japan’s Pharma — JPMA 2024 R Survey highlights:

• 60%+ of companies use R
• 16 have used/plan to use R for FDA/PMDA submissions
• 25% use pharmaverse (admiral, rtables, pkglite)
• 80%+ are interested in submitting Shiny apps (Pilot 4 style)

Join the R Consortium × JPMA webinar + live Q&A.

Speakers: Shinichi Hotta (Sumitomo), Yuki Matsunaga (Novartis)

Register: r-consortium.org/webinars/open

NEXT WEEK! R Consortium webinar: Open Source Software Adoption in Japan's Pharma Industry

Key highlights:

-- Over 60% of companies have adopted R; 16 have used or plan to use R for regulatory submissions (e.g., FDA, PMDA).

-- 25% are actively using pharmaverse packages such as Admiral, rtables, and pkglite.

-- More than 80% expressed interest in submitting R Shiny applications, similar to the R Consortium’s Pilot 4.

Register for free: r-consortium.org/webinars/open

Why can't Medicare and Medicaid to this, @rokhanna.bsky.social‬ ?

@ddayen@bsky.social: Ohio took the power to manage prescription drugs away from private companies & gave it to the state. It was wildly successful: savings for the government, much higher reimbursement for #pharmacists & better access to medicines for residents.

On #OrganizedMoney we talked to the guy who made it happen

organizedmoney.fm/p/the-pbm-hi

Organized Money · The PBM HitmanAv David Dayen

The FDA found that Sun Pharma, which produces generic drugs for U.S. consumers, failed to investigate the source of bacteria found in test vials or promptly deal with damaged equipment that had caused drugs to be contaminated with metal particles.

propublica.org/article/fda-dru

ProPublicaFDA Inspectors Again Find Dangerous Breakdowns at an Indian Factory Supplying Medications to U.S. Consumers
Mer fra ProPublica

Pharma and life sciences folks! Join us at posit::conf(2025) for workshops on:

- Deploying Reproducible Analytics Environments for Regulated Use Cases with Becca Krouse (GSK) and Daniel Sjoberg (Genentech)
- End-to-End Submissions in #RStats with the #Pharmaverse with James Black (Novartis), Orla Doyle (Novartis), Doug Kelkhoff (Roche), Michael Mayer (Posit), and Rafael Pereira (@appsilon)

Update your skills for compliance & efficiency. Learn more: pos.it/conf-2025-workshops

#Organon beendet die Entwicklung des #Schmerzmittels OG-6219 zur Behandlung von #Endometriose, da eine Phase-2-Studie keinen Nutzen gegenüber Placebo zeigte.

Der Wirkstoff sollte Schmerzen lindern, blieb jedoch hinter den Erwartungen zurück. Trotz des Rückschlags betont das Unternehmen seinen Fokus auf #Frauengesundheit. OG-6219 stammt aus dem Zukauf von Forendo Pharma.

de.investing.com/news/company-

Trump’s plan to slap massive tariffs on Aussie copper and pharmaceuticals isn’t about protecting jobs — it’s about protecting profits. US pharma giants hate our PBS because it stops them price gouging. Now they’re using trade threats to try and tear it down.
This is capitalism doing what it does best — punishing ordinary people so corporations can keep raking it in. Australia must hold the line. Our health system isn’t up for sale.

#pbs #pharma #auspol #trump #corporategreed #tradewars #healthcare #anticapitalism

theage.com.au/politics/federal

The Age · Chalmers rules out using PBS as bargaining chip in face of Trump’s pharma tariffsAv Olivia Ireland, Simon Johanson
Fortsettelse av samtale

Update. Three past editors of the New England Journal of Medicine (#NEJM) answer the attack on their journal from #RFKJr.
statnews.com/2025/06/30/rfk-jr
(#paywalled)

"Kennedy claimed that one of us (Angell) said, 'We are no longer a science journal, we are a vessel for pharmaceutical propaganda.' In fact, what Angell said in a 2009 article was that 'it is simply no longer possible to believe much of the clinical research that is published,' due to researchers’ financial ties with pharmaceutical companies."

The editors also point out that the three journals named by Kennedy happen to have published editorials criticizing the #Trump admin assault of science.

STAT · RFK Jr. says medical journals are ‘corrupt.’ As former NEJM editors, we know he’s wrongRFK Jr.’s plan to circumvent established medical journals smacks more of retaliation than reform, write three former NEJM editors.